Commercial multiplex assays, built on different chemistries and platforms are widely 25 available for simultaneous detection of pathogens that cause respiratory infections. However, 26 these tests are often difficult to implement in a resource limited setting because of high cost. In 27 this study, we developed and validated a method for simultaneous testing of common respiratory 28 pathogens (Respanel) by real-time PCR in a convenient, strip-tube array format. Primers and 29 probes for sixteen PCR assays were selected from the literature or newly designed. Following 30 optimization of individual PCR assays, strip-tube arrays were prepared by dispensing primer-31 probe mixes (PPM) into two sets of 8-tube strips. Nucleic acid extracts from specimens were 32 mixed with PCR master mix, and dispensed column-wise into 2X8-wells of a 96-well plate. 33 PPMs from strip-tubes were then added to the wells using a multichannel pipette for real-time 34 PCR. Individual PCR assays were optimized using previously known specimens (n=397) with 35 91%-100% concordance with culture, DFA or PCR results. Respanel was then tested in a routine 36 manner at two different sites using specimens (n=147) previously tested by Qiagen Resplex I&II 37 or Fast-Track Diagnostics Respiratory Pathogens 21 assays. The sensitivity, specificity and 38 accuracy of Respanel were 94%, 95% and 95%, respectively, against Resplex and 88%, 100% 39 and 99%, respectively, against FTDRP21. Respanel detected 48% more pathogens (p<0.05) than 40 Resplex but the rate of pathogen detection was not significantly different from FTDRP21.
multiplex PCR assay to detect a total of 23 pathogen targets (28) . The test kit provides reagents 93 only and the users can run the tests using their own nucleic acid extraction platforms and real-94 time PCR systems. 95 While most commercial assays are rapid and convenient and their performance 96 characteristics meet regulatory requirements, they are invariably expensive, which may be 97 difficult to implement in resource poor settings. Also, commercial test kits are not uniformly 98 available throughout the world. Timely delivery of test kits and reagents are critical for smooth 99 operation of diagnostic laboratories and a delay in shipping may adversely affect the 100 management of patients with respiratory infections. Furthermore, commercial tests are not free of acids from 0.5 ml of NPW or NPFS specimens were extracted on a NucliSENS® easyMAG 139 platform (bioMérieux, France) according to the methods described by the manufacturers.
140
Real-time PCR: Primers and probes for sixteen PCR assays were either obtained from 141 previously published assays or newly designed, in this study by using the Primer Express 142 software v3.0.1 (Life Technologies) ( Table 1) performed in a ABI7500 Fast instrument (Thermofisher Scientific, USA) with 1 cycle of reverse 156 transcription at 50°C for 30 min followed by 1 cycle of denaturation at 95°C for 15 min, QuantiTect RT Mix (Qiagen, USA). Ten percent extra volume was added to the required volume plate, in the two adjacent columns containing the primers and probes as described above and in The purpose of this study was to develop a laboratory-developed, real-time PCR based 271 test panel for selected respiratory pathogens with minimum multiplexing and in a format so that 272 minimum hands-on time is required. Accordingly, we designed our workflow so that assay 273 specific reagents are ready to be used for routine testing (Figure 1) . We also minimized repeated 274 pipetting through the use of multichannel pipettes for faster transfer of reagents and to prevent 275 pipetting error. The pre-aliquoted primer and probe mixes in 8-tube strips can be prepared once in 3 months, 6 months or 1 year according to laboratory needs. Preparation of primer/probe 277 mixes and strip tubes for Panel I and II may take one FTE technologist time for up to 8 hours. 278 We noted that in an automated liquid handler (Perkin Elmer, USA), preparation of 200 test strips 279 takes about 2 hour time.
280
After initial optimization of PCR conditions, Respanel assay was validated in three steps. Coronavirus OC43  3  110  3  110  100  Coronavirus NL63  5  108  4  109  99  Coronavirus HKU1  2  111  1  112  99  Total  78  1843  82  1839  99 425 
